SUPRIYA — Supriya Lifescience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Supriya Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	747	923	2,339	1,640	795
Net Total Accounts Receivable
Net Total Receivables	569	826	1,327	1,523	2,015
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,980	2,655	4,975	4,649	3,978
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,350	1,772	2,317	3,281	4,573
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3,364	4,455	7,348	8,203	9,212
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,554	1,460	997	958	769
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,872	1,769	1,191	1,208	1,059
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,492	2,686	6,157	6,995	8,154
Total Liabilities & Shareholders' Equity	3,364	4,455	7,348	8,203	9,212
Total Common Shares Outstanding